Novo Nordisk

For 95 years, Novo Nordisk, a global leader in diabetes care, has been committed to discovering and developing innovative medicines to help people with chronic diseases lead longer, healthier lives.
Featured Products
![]() |
![]() |
![]() |
Literature
Ozempic and cardiovascular outcomes in patients with type 2 diabetes |
Ozempic versus Trulicity once weekly in patients with type 2 diabetes: a randomized, open-label phase 3b trial |
Novo Nordisk Contact Information |
![]() |
Melissa Harakuni |
323.243.0424 |
mlhz@novonordisk.com |
novonordisk.us |